The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Warfarin Teva 6 mg Tablets

Sun Pharmaceutical Industries Europe B.V.PA2050/001/007

Main Information

Trade NameWarfarin Teva 6 mg Tablets
Active SubstancesWarfarin sodium clathrate
Dosage FormTablet
Licence HolderSun Pharmaceutical Industries Europe B.V.
Licence NumberPA2050/001/007

Group Information

ATC CodeB01AA Vitamin K antagonists
B01AA03 warfarin


License statusAuthorised
Licence Issued26/10/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back